KT&G Receives Presidential Award at "2023 Cultural Awards" Ceremony

Events by 2FIRSTS.ai
Nov.23.2023
KT&G Receives Presidential Award at "2023 Cultural Awards" Ceremony
KT&G announced their win at the 2023 Cultural Awards ceremony, receiving the Presidential Award for their contributions to the arts.

According to Naver, KT&G Corporation announced at the "2023 Culture Awards" ceremony held at The Westin Chosun Hotel in central Seoul on November 22nd that they have received the Presidential Award, making them the recipient of the highest honor for this award.

 

Since 1999, the "Cultural Awards," organized by the Cultural Award Association, have been annually selecting and recognizing enterprises that have made outstanding contributions in the domestic cultural and artistic fields.

 

KT&G, the South Korean tobacco company, has once again been recognized for its efforts in cultivating cultural and artistic talent and fostering community engagement. The company's comprehensive cultural and arts space, KT&G Fantasy Square, which is located in five different locations across the country, has served as the cornerstone for these endeavors. Following its previous recognition in 2015, KT&G has once again been honored for its commitment to supporting emerging artists and providing the public with a diverse range of cultural experiences, including performances, art exhibitions, photography, and film screenings.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
AIRSCREAM Solidifies South African Leadership & Championing Truth in Vaping
AIRSCREAM Solidifies South African Leadership & Championing Truth in Vaping
As South Africa’s leading lifestyle vaping brand, AIRSCREAM is accelerating its regional growth strategy with the launch of its bold new initiative, “Trust ML, Not Puff.” The campaign calls for factual, millilitre (ml)-based transparency across the vaping industry, directly confronting misleading puff-count marketing practices and promoting clear, standardised information that reflects the true value and capacity of vaping products.
Nov.28
Russian lawmakers propose total ban on e-cigarette sales, in response to Putin's call for protection of youth health
Russian lawmakers propose total ban on e-cigarette sales, in response to Putin's call for protection of youth health
Russian Duma members propose nationwide ban on e-cigarette sales in response to Putin's call for youth health protection.
Nov.28 by 2FIRSTS.ai
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
According to Bloomberg, Dubai-based hookah brand owner Advanced Inhalation Rituals (AIR) plans to go public on Nasdaq in the first half of 2026 through a merger with a Cantor Fitzgerald-backed SPAC. The deal values the combined company at USD 1.75 billion under the ticker “AIIR.”
Nov.11
South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances
South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances
South Korea has enacted the Tobacco Harm Management Act, effective November 1, 2025, requiring tobacco manufacturers and importers to test and report harmful substances in their products every two years. Results for all tobacco types—including combustible cigarettes, heated tobacco, and e-cigarettes—will be publicly available from mid-2026.
Nov.04 by 2FIRSTS.ai
South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine
South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine
South Korea’s amendment to the Tobacco Business Act, which would classify synthetic nicotine vapes and vape liquids as “tobacco” for regulatory and taxation purposes, has been delayed once again. Despite the government stressing its urgency due to youth access and risks of illicit drug mixing, both ruling and opposition parties at the Legislation and Judiciary Committee meeting agreed that the bill requires further discussion.
Nov.13 by 2FIRSTS.ai